Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304147 · ClinicalTrials.gov registry record · NA
Intranasal Ketamine in Treatment-Resistant Depression
A NA study, sponsored by James Murrough.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01304147 is a NA study that has completed, run by James Murrough. The registered enrollment target is 20 participants.
The verdict
NCT01304147, a NA study, has completed, sponsored by James Murrough.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of the current study is to investigate the safety and efficacy of a single dose of intranasal (IN) ketamine in treatment-resistant depression (TRD).
Interventions
- DRUG placebo
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01304147
The ClinicalTrials.gov registry entry for NCT01304147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is James Murrough, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01304147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01304147 about?
NCT01304147 is a clinical study titled "Intranasal Ketamine in Treatment-Resistant Depression". The objective of the current study is to investigate the safety and efficacy of a single dose of intranasal (IN) ketamine in treatment-resistant depression (TRD).
What is the current status of trial NCT01304147?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-10. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01304147?
The interventions under investigation include: placebo (DRUG), Ketamine (DRUG).
Who is sponsoring clinical trial NCT01304147?
This trial is sponsored by James Murrough, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.